Summary: Previous studies utilizing crude brain homoge nates have shown that forebrain ischemia results in inhi bition of calcium/calmodulin-dependent protein kinase II (CaM kinase II) activity without large-scale proteolysis of the enzyme. In this report, a monoclonal antibody (lC3-3D6) directed against the 13-(60-kDa) subunit of CaM kinase II that does not recognize ischemically altered enzyme was utilized to further investigate the ischemia induced inhibition of CaM kinase II. Immunohistochemi cal investigations showed that the ischemia-induced de creased immunoreactivity of CaM kinase II occurred immediately following ischemic insult in ischemia sensitive cells such as pyramidal cells of the hippocam pus. No decrease in CaM kinase II immunoreactivity was observed in ischemia-resistant cells such as granule cells Cerebral ischemia produces morphological and functional modifications in neurons that can result in delayed neuronal death (Pulsinelli and Brierly, 1979; Kirino, 1982; Churn et aI., 1990a,b). Alter ation of calcium homeostasis and calcium-depen dent mechanisms may play a critical role in the isch emia-induced cascade of events resulting in delayed neuronal cell death. The involvement of calcium dependent protein kinase systems in the regulation
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of cell function has been intensely investigated in recent years. Calcium-dependent protein phospho rylation modulates many neuronal processes in cluding neurotransmitter synthesis and release (De Lorenzo and Freedman, 1978; Albert et aI., 1984;  Vulliet et aI., 1984; Nose et aI., 1985; Griffith and Schulman, 1988; Nichols et aI., 1990) , synaptic ves icle mobilization (DeLorenzo et aI., 1979; Llinas et aI., 1985; Hemmings et aI., 1989) , postsynaptic events such as cytoskeletal dynamics (Jameson et aI., 1980; Burke and DeLorenzo, 1982; Yamamoto et aI., 1985) , and regulation of membrane conduc tances (Sakakibara et aI., 1986) . Therefore, alter ation of neuronal calcium-dependent protein kinase systems by ischemia may play a role in mediating some of the effects of calcium in ischemia-induced cell death.
Calcium-dependent protein phosphorylation has been shown to be very sensitive to the effects of ischemia (Goldenring et aI., 1983; Wasterlain and Powell, 1986; Taft et al., 1988; Churn et al., 1990a ,b, Zivin et aI., 1990 . Thus, inhibition of pro tein phosphorylation may represent a pathway lead ing to alteration of neuronal function and possibly neuronal cell death. To investigate the effects of ischemia on protein phosphorylation, our labora tory has concentrated on studying the ischemia-in duced inhibition of the multifunctional calcium/ calmodulin-dependent protein kinase II (CaM ki nase lI). CaM kinase II activity is inhibited immedi ately after 5 min of ischemia, and the inhibition remains until significant neuronal necrosis is ob served (Taft et aI., 1988; Churn et aI., 1990a) . In addition, the decrease in CaM kinase II activity is not likely to be due to large-scale proteolysis. No significant differences are observed in CaM kinase II subunit levels or calmodulin binding properties in forebrain homogenates (Taft et aI., 1988 , Churn et aI., 1990a or purified CaM kinase II enzyme frac tions (Churn et aI., 1991) isolated from control and ischemic animals. In this report, we characterize a monoclonal IgG 3 antibody directed against CaM ki nase II and describe the ischemia-induced decrease in immunoreactivity with CaM kinase II both in vitro and in situ. The data indicate that ischemia produces a posttranslational modification of CaM kinase II that alters the ability of the antibody to recognize the f3-subunit of the enzyme. Character ization of this monoclonal antibody may provide a powerful resource for investigating the role of CaM kinase II in cerebral ischemia.
METHODS AND MATERIALS

Materials
All materials are reagent grade unless otherwise spec ified. [-y_3 2 p]ATP was purchased from New England Nu clear (Wilmington, DE, U.S.A.) . Nitrocellulose mem brane (0.45 fl.m) was purchased from Bio-Rad (Richmond, CA, U.S.A.). Purified calmodulin was purchased from Pharmacia (Piscataway, NJ, U.S.A.).
Gerbil ischemia model
Bilateral carotid occlusion was performed as previ ously described (Churn et a!., 1990a,b) . Briefly, male Mongolian gerbils (Meriones unquiculatus) weighing 50-70 g were anesthetized under 2.5% halothane/60% nitrous oxide/40% oxygen and placed on a heated surgical table. The ventral neck area was soaked with Operanol (Redi Products) and shaved using a safety razor. An incision was made by lifting the skin above the sternum and mak ing two to three cuts directed rostrally up the neck. Chest muscles were separated from the trachea by a stripping motion parallel to the trachea to expose the carotid arter ies.
To induce ischemia, the carotid arteries were raised and Heifitz aneurysm clips were attached. After 5 min of occlusion, the aneurysm clips were removed and recirculation was confirmed visually. The skin was folded over and the wound sutured with 5-0 silk. Surgery, ischemia, and wound closure required 16-20 min. Temperature was monitored continuously during surgery via a lubricated rectal probe (YSI).
CaM kinase II reactions
CaM kinase II was purified by standard column chro matography (Goldenring et a!., 1983) . Purified Sephacryl fractions (> 1 ,OOO-fold enrichment) or highly enriched cal modulin-Sepharose fractions (>400-fold enriched) were used in the assays.
For auto phosphorylation studies, CaM kinase II was reacted under standard conditions, except where noted (Goldenring et aI., 1983; Churn et a!., 1990a) . Standard phosphorylation reaction solutions contained 10 mM pi perazine-N-N' -bis[2-ethanesulfonate] (pH 7.4), 10 mM MgCI 2 , and 7 fl.M [-y_3 2 p]ATP. For maximal CaM kinase II activity, 5 mM CaCl 2 and 1 fl.g calmodulin were in cluded. Reactions were initiated with the addition of cal cium, continued for 1 min, and then terminated by the addition of 5% sodium dodecyl sulfate (SDS) stop solu tion. Proteins were resolved by SDS polyacrylamide gel electrophoresis (PAGE) (Laemmli, 1970) and either sub jected to Western analysis or stained for protein resolu tion with Coomassie Brilliant Blue or the more sensitive silver stain as previously described (Goldenring et aI., 1983; Churn et a!., 1990a) . Stained gels were dried and exposed to x-ray film (XRP-l; Kodak, Rochester, NY, U.S.A.) for autoradiography.
Development of monoclonal antibody
Mice (Mus musculus, BALB-c; Charles River) were immunized with two intraperitoneal injections (100 fl.g/ injection, 21 days apart) of purified CaM kinase II. Thirty days following the second injection, the mice were killed by cervical dislocation, and a spleen cell suspension was made. The splenocytes were fused with a nonsecreting mouse myeloma cell line (P3X63-AG8.653). Monoclonal producing cells were obtained from antibody-secreting poly clonal hybridomas by limited dilution methods (Ken net, 1979) . Sub typing of antibody directed against CaM kinase II was performed by enzyme-linked immunoassay (ELISA) (Kennet, 1979) .
Specificity of lC3-3D6
The specificity of the monoclonal antibody was tested by Western analysis. Samples of crude homogenate or purified CaM kinase II were resolved on one-dimensional 8.5% SDS-PAGE or two-dimensional isoelectric focusing gels combined with SDS-PAGE and electroblotted onto nitrocellulose (Goldenring et aI., 1982; Churn et aI., 1990a) . The nitrocellulose was immersed in phosphate buffered saline (PBS; IO mM NaP04/0.9% NaCI, pH = 7.5), containing Tween-20 (TPBS; Sigma, St. Louis, MO, U.S.A.). The strip was incubated in antibody-containing TPBS for I h and washed by three changes of TPBS. The blot was incubated in a solution of biotinylated secondary antibody in TPBS. Excess secondary antibody was washed by three changes of PBS and labeled proteins were reacted with an alkaline phosphatase-staining kit (Vector).
In addition to Western analysis, ELISA was performed to observe linearity of immunoreactivity with respect to CaM kinase II concentration or antibody concentration. ELISA plates were coated with varying amounts of CaM kinase II for 24 h. The coated plates were washed with TPBS. Background was decreased by incubating coated plates in blocking solution (5 g Carnation Milk/loo ml PBS). Blocked plates were incubated with antibody for 2 h and then washed four times with TPBS. The washed plates were incubated with peroxidase-conjugated anti mouse IgG for 2 h. Staining was performed by reacting plates with substrate solution (Vector) and wells were read at OD 405 nm on an EIA reader (Biotech, Winooski, VT, U.S.A.).
Immunohistochemistry and histology
For histological slides, gerbils were subjected to isch emia or sham operation as described above. At the spec ified times postischemia, the animals were killed and per fused and the brains processed for histological examina tion as described previously (Churn et aI., 1990a) . Coronal sections of brain were dehydrated in a series of ethanol and xylene baths prior to paraffin embedding. Serial sections 7 J..l m thick containing the dorsal hippo campus were cut using an American Optical AL micro tome (Buffalo, NY, U.S.A.), mounted on slides, and stained with cresyl violet.
For immunocytochemical studies, animals were anes thetized with an injection of sodium pentobarbital (50 mg/ kg i.p.). Gerbils were then transcardially perfused with saline followed by fixative composed of 4% paraformal dehyde/O.l M phosphate buffer. After fixation, the brains were removed and placed in fresh fixative for an addi tional hour. They were stored in phosphate buffer at 4°C until sectioned. For sectioning, the harvested brain ma terial was blocked in a sagittal plane and 40-j.tm semiserial sections were cut with a vibratome. The sections were washed in PBS (pH 7.2), incubated for 1 h in 10% normal horse serum (NHS)/0.3% Triton-X, and then incubated in a solution of lC3-3D6 diluted 1: 1 ,000 into 1% NHS in PBS for 18 h at 4°C. Following incubation in the primary antibody, the sections were washed 10 min in 1% NHS in PBS and then incubated for 60 min in biotinylated anti mouse IgG (Vector) diluted into 1% NHS/PBS. The sec tions were washed 10 min in PBS and then immersed for 1 h in avidin-biotin-horseradish peroxidase complex (Vector). Incubated sections were washed 10 min in PBS and transferred to a development chamber. The sections were reacted in 0.05% diaminobenzidene and 0.01% hy drogen peroxide for 5 min. Following diaminobenzidene reaction, the sections were mounted onto glass slides, dehydrated, cleared, and covered with a coverslip.
RESULTS
Specificity of monoclonal IgG3 anti-CaM kinase II
The selectivity of lC3-3D6 for the (3-subunit of CaM kinase II is shown in Fig. 1 . In crude homoge nate fractions, lC3-3D6 reacted with a band of �60 kDa molecular mass. The monoclonal lC3-3D6 did not react with any other protein within the crude homogenate fraction. Highly purified CaM kinase II was subjected to Western analysis and reacted with lC3-3D6 as described in Materials and Methods. A similar band of 60 kDa molecular mass was ob served in the purified fraction as seen in the crude protein fraction. The 60-kDa band identified by -2) , which was shown to be the l3-subunit of CaM kinase II (lane 3). When analyzed in high concentration, a minor band of -58 kOa was also observed in both crude and purified frac tions. The minor band co-migrates with the 13'-subunit of CaM kinase II (Bennett and Kennedy, 1987) .
lC3-3D6 co-migrated with the (3-(60-kDa) subunit (Goldenring et aI., 1983; Bennett and Kennedy, 1987) of highly purified CaM kinase II (Fig. I) . A minor band of molecular mass 58 kDa was also identified when high concentrations of protein were studied in both the crude homogenate and the puri fied fractions of CaM kinase II (Fig. 1 ). This band co-migrated with the 13' -subunit of CaM kinase II identified by Bennett and Kennedy (1987) . Immunochemical analysis of CaM kinase II sub jected to two-dimensional SDS-PAGE was per formed to further investigate the remote possibility that a 60-kDa contaminating protein was the immu noreactive agent observed in Fig. 1 . Western anal ysis was performed on highly purified CaM kinase II, which was subjected to two-dimensional isoelec tric focusing and SDS-PAGE. The monoclonal lC3-3D6 reacted with a band of 60-kDa molecular mass and with an isoelectric point of �6.9 (data not shown). The immunoreactive peptide co-migrated with the 3 2P-Iabeled and protein-stained l3-subunit of CaM kinase II identified in the same gel. Thus, lC3-3D6 reacted with a peptide of 60 kDa molecular mass that co-purified with CaM kinase II and has the same isoelectric point as the l3-subunit of CaM kinase II. The data indicate that lC3-3D6 selec tively recognized the 13-and 13' -subunits of CaM kinase II.
Linearity range of immunoreactivity with lC3-3D6
A standard curve for immunoreactivity of CaM kinase II with lC3-3D6 was performed utilizing ELISA. The immunoassay with purified CaM ki nase II was linear over a concentration range from 30 to 760 ng (�6-150 ng l3-subunit, correlation co efficient = 0.972, p < 0.001, different from 0, two tailed Student t test, n = 18; Fig. 2A) . A CaM ki nase II concentration of 380 ng, which was in the middle of the linear portion of the curve, was used CaM kinase II ('9) B.
1.5 r----------, to perform a standard titration curve for the con centration of lC3-3D6 (Fig. 2B) . A linear curve was generated with an antibody range of 0.027 j.1g to the highest concentration tested, 0.54 j.1g (correlation coefficient = 0.967, p < 0.001, different from 0, two-tailed Student t test, n = 18). This represented a dilution curve of 1 :2,000 to 1: 1. Therefore, for immunohistochemical studies, a dilution of 1: 1 ,000 (0.054 j.1g lC3-3D6/j.11 reaction volume) was used to reduce background, yet remain in the linear portion of immunoreactivity.
Decreased immunoreactivity of CaM kinase II resulting from ischemia
In the gerbil, 5 min of global forebrain ischemia causes a decrease in CaM kinase II activity without changing total protein levels or calmodulin binding properties of the enzyme (Taft et aI., 1988; Churn et aI., 1990a,b) . Ischemia produced a decrease in im munoreactivity of CaM kinase II demonstrated by Western analysis both in starting homogenate frac tions and in highly enriched calmodulin-Sepharose eluant (Fig. 3) . The decreased immunoreactivity was in agreement with activity observed in purified (> 1 ,OOO-fold) fractions (Churn et aI., 1990b (Churn et aI., , 1991 . Immunoreactivity of CaM kinase II was reduced 57.6 ± 10.5% in a fraction exhibiting 55% inhibition of CaM kinase II activity ( Fig. 3C ; p < 0.01, Stu dent t test, n = 4). The decreased immunoreactivity occurred in fractions where equivalent protein staining and calmodulin binding of the (X-and l3-sub units were observed (Taft et aI., 1988; Churn et aI., 1990a,b) (Fig. 3) . The data suggest that global fore brain ischemia in the gerbil induced a posttransla tional modification of CaM kinase II that did not affect calmodulin binding or total protein levels sig nificantly but reduced antibody recognition of the enzyme.
Effect of autophosphorylation on immunoreactivity of CaM kinase II
The extent of autophosphorylation has been shown to alter the immunoreactivity of CaM kinase II with some monoclonal antibodies (Hendry and Kennedy, 1986) . Therefore, we investigated whether autophosphorylation alters immunoreac tivity with 1C3-3D6 (Fig. 4) . CaM kinase II was reacted under standard conditions (7 j.1M ATP), re solved on SDS-PAGE, and subjected to Western analysis with >80% transfer efficiency. In addition to standard reactions, reactions where the level of ATP was increased to 500 j.1M were performed (Lou et aI., 1986) . Autophosphorylation of CaM kinase II at either standard (7 j.1M) or high (500 j.1M) levels of ATP did not alter immunoreactivity with 1C3-3D6. Therefore, changes in immunoreactivity of CaM ki nase II with lC3-3D6 are not secondary to auto phosphorylation of the enzyme. subregions of the hippocampus (Pulsinelli and Bri erly, 1979; Kirino, 1982; Churn et aI., 1990a,b) (Fig.  5) . Histological loss of pyramidal neurons is not ob served until 3-4 days following 5 min of global fore brain ischemia and fully developed after only 7 days (Pulsinelli and Brierly, 1979; Kirino, 1982; Churn et aI., 1990a,b) (Fig. 5C-F) .
To further study the effects of ischemia on the immunoreactivity of CaM kinase II with lC3-3D6, immunohistochemistry was performed on brains harvested from naive and ischemic animals. Local ization of forebrain immunoreactivity observed with lC3-3D6 is similar to that observed or a mono clonal antibody directed against the a-subunit of CaM kinase II (Ouimet et a!., 1984a,b; Erondu and Kennedy, 1985; Odonera et aI., 1990) . CaM kinase II is concentrated in neuronal cells and is especially prominent in the pyramidal cells of the hippocam pus, cortical neurons, and striatal neurons. In addi tion to the forebrain, significant immunoreactivity toward lC3-3D6 was observed in the cerebellum (data not shown).
Loss of CaM kinase II activity is observed in the hippocampus immediately following 5 min of global forebrain ischemia in the gerbil (Taft et aI., 1988; Churn et aI., 1990b) . Loss of immunoreactivity oc curs within 30 min in hippocampal cells, which show significant delayed neuronal loss following 5 min of global forebrain ischemia (Fig. 6) . In addi tion, the loss of immunoreactivity is observed at both 2 and 24 h of reperfusion (data not shown). This loss is observed before the histological damage induced by 5 min of global forebrain ischemia (Figs. 5 and 6). Thus, the ischemia-induced loss of immu noreactivity with lC3-3D6 occurs only in neurons that show significant histological cell loss after tran sient global forebrain ischemia. In addition, loss of immunoreactivity with lC3-3D6 significantly pre cedes histological observation of ischemia-induced neuronal necrosis.
DISCUSSION
CaM kinase II is an important neuronal enzyme that is significantly inhibited in several models of ischemia, including the gerbil global forebrain isch emia model (Taft et aI., 1988; Churn et aI., 1990a,b) , the rabbit spinal chord ischemia model (Zivin et aI., 1990) , and decapitation ischemia in the rat (Golden ring et aI., 1983; Wasterlain and Powell, 1986) . Isch emia has also been shown to alter immunoreactivity of CaM kinase II with monoclonal antibodies di rected against the enzyme (Wasterlain and Powell, 1986; Churn et aI., 1991) . CaM kinase II has been purified from control and ischemic gerbils, and when balanced for protein staining and calmodulin binding, the ischemia-induced inhibition of the en zyme remained. The previous observations support the hypothesis that ischemia induced a posttransla tional modification of CaM kinase II (Churn et al., 1990a (Churn et al., ,b, 1991 . In this report, we characterized a monoclonal antibody directed against the l3-subunit of CaM kinase II. It was demonstrated that isch emia induced an alteration of CaM kinase II that resulted in decreased immunoreactivity of the en zyme. The decreased immunoreactivity was not due to autophosphorylation of the enzyme and oc curred under conditions that did not alter the con centration of protein staining or calmodulin binding of the l3-subunit of the kinase. The monoclonal IgG 3 antibody developed in this study was highly selective for the l3-subunit of CaM kinase II. Immunoreactivity of 1C3-3D6 in a crude homogenate fraction was specific to a 60-kDa band on SDS-PAGE. This band was shown to be the l3-subunit of CaM kinase II by Western blot analysis of purified enzyme with lC3-3D6 on one-and two dimensional PAGE systems. The monoclonal lC3-3D6 antibody reacted with a peptide displaying the same molecular mass and the same isoelectric point of the l3-subunit of CaM kinase II (Goldenring et aI., 1983) . Ischemia resulted in decreased immunoreac tivity of CaM kinase II when studied by Western analysis. The decreased immunoreactivity was ob served in both crude homogenate and highly en riched fractions. This decreased immunoreactivity agrees with data shown in other models of ischemia such as the Levine preparation (Wasterlain and Powell, 1986; Odonera et aI., 1990) . The mecha nisms whereby ischemia produces alterations in CaM kinase II immunoreactivity are not presently known. To investigate the ischemia-induced alter ation(s) of CaM kinase II, mapping of the 1C3-3D6 recognition site will be performed. Autophosphorylation of CaM II kinase has been shown to alter both enzymatic activity (Lai et aI., J Cereb Blood Flow Metab. Vol. 12. No.5. 1992 1986; Lou et aI., 1986; Nichols et aI., 1990) and immunoreactivity (Hendry and Kennedy, 1986) . Therefore, we studied whether autophosphoryla tion of CaM kinase II resulted in decreased immu noreactivity of the enzyme with lC3-3D6. Under standard conditions, ATP has been shown to mod ulate the kinetics of CaM kinase II autophosphory lation (Lou and Schulman, 1986) . Low ATP con centrations, such as those around the Kd for ATP (7 fLM), resulted in autophosphorylation that leads to inhibition of the enzyme. However, in the presence of high ATP levels (500 fLM), which are closer to physiological ATP concentrations, autophosphory lation does not lead to inhibition of the enzyme. Since the level of ATP modulates the extent of autophosphorylation, CaM kinase II was reacted under standard conditions in the presence of both low (7 fLM) and high (500 fLM) ATP. Immunoreac tivity of CaM kinase II with lC3-3D6 was not al tered after extensi'/e autophosphorylation of the en zyme at either ATP level. Therefore, the ischemia induced decrease in immunoreactivity of CaM kinase II was not due to autophosphorylation of the enzyme.
Previous studies provide evidence that the isch emia-induced inhibition of CaM kinase II activity may be involved in the cascade of events resulting in delayed neuronal cell death. First, CaM kinase II activity is decreased at an early time point following global ischemia in the gerbil and remains inhibited until significant cell loss is observed (Taft et aI., 1988; Churn et aI., 1990b) . In addition, parameters that modulate the extent of neuronal cell loss, such as intraischemic temperature, modulate the extent of CaM kinase II inhibition in a parallel manner (Churn et aI. , 1990a,b) . To further investigate whether CaM kinase II inhibition might be involved with delayed neuronal cell loss, immunohistochem istry was performed on brain sections from isch-emic gerbils. Loss of CaM kinase II immunoreac tivity was noted in the CAl_ 3 subregions of the hip pocampus. Under the conditions of ischemia, these are the cell populations that are most sensitive to the effects of ischemia (Pulsinelli and Brierly, 1979; Kirino, 1982; Churn et al., 1990a) . No significant loss of immunoreactivity or neuronal necrosis was observed in ischemia-resistant cells such as in the dentate gyrus. What is significant about the alter ation in immunoreactivity of CaM kinase II is that it occurs rapidly, long before cell loss is noted. Loss of CaM kinase II activity following ischemia is ob served after 10 s and persists until significant cell loss occurs (Taft et al., 1988; Churn et al., 1990b) . The decreased immunoreactivity of CaM kinase II with lC3-3D6 occurs within 30 min following the ischemic insult and remains after 24 h of reperfu sion. Thus, decreased immunoreactivity of CaM ki nase II is an early event following ischemia and occurs in cells that are sensitive to the effects of ischemia. Ischemia results in decreased immunore activity that temporally parallels the ischemia induced inhibition of CaM kinase enzymatic activ ity and precedes ischemia-induced neuronal cell loss. Since the loss of immunoreactivity of CaM kinase II parallels the histological loss of neuronal cells, the immunohistochemistry studies provide further evidence that alteration of CaM kinase II activity may be involved in the cascade of events that ultimately result in neuronal death. The anti body may also be a useful early marker of cells that have sustained significant ischemic injury and will ultimately die.
CaM kinase II has been successfully isolated from ischemic gerbils (Churn et all., 1990b (Churn et all., , 1991 . Ischemic CaM kinase II displays equivalent cal modulin and substrate recognition and reaction ki netics when compared with control enzyme (Churn et al., 1991) . In this report, it was shown that isch emia alters CaM kinase II, which results in de creased immunoreactivity of the enzyme. This de creased immunoreactivity is not due to autophos phorylation of the enzyme, nor is it due to significant proteolysis. The data from this study, in combination with previously described results (Taft et al., 1988; Churn et al., 1990a,b) suggest that isch emia induces a posttranslational alteration of CaM kinase II, which results in decreased immunoreac tivity of the enzyme. Since the decreased immuno reactivity occurs in cells that are sensitive to the effects of ischemia, alteration of CaM kinase II may be important in the cascade of events that result in ischemia-induced delayed neuronal cell death. The use of lC3-3D6 as a marker of the ischemia-induced postranslational modification of CaM kinase II will provide a powerful tool to study the role of this major enzyme system in stroke.
